Investigators developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to ...

Sarcomas are highly metastatic soft tissue and bone cancers and are often difficult to treat. Scientists have had trouble ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient ...

Orphan Drug Designation in Soft Tissue Sarcomas Expands Company’s Potential to Address Cancers with High Unmet Medical Need CHICAGO and FORT WORTH, Texas, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Actuate ...

Fort Worth, Texas, clinical-stage biopharmaceutical company Actuate said elraglusib has shown a favorable safety profile and antitumor activity across several solid tumors, including melanoma, Ewing ...

"Soft tissue sarcomas are a rare but heterogeneous mix of tumors with ... "would," or the negative of these terms or other comparable terminology are intended to identify forward-looking statements, ...

This case demonstrates the pivotal role of a cohesive multidisciplinary team in navigating the complex care of oncology ...

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Thymic Carcinoma.

There are around 100 different subtypes of sarcoma that can be classified into three broad groups: soft tissue sarcoma ... Here, the authors identify a crosstalk mechanism between tumor and ...

Mark Kris Named the 2024 Evening of Innovation Gala Honoree by the Lung Cancer Research Foundation Cristina Antonescu ...